Dronabinol for Pain Management in Traumatic Injury
(DOPE Trial)

Recruiting in Palo Alto (17 mi)

Overseen byJohn Harvin, MD, FACS

Age: Any Age

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 4

Waitlist Available

Sponsor: The University of Texas Health Science Center, Houston

Stay on Your Current Meds

No Placebo Group

Prior Safety Data

Approved in 6 Jurisdictions

Trial Summary

What is the purpose of this trial?The purpose of this study is to identify the effect dronabinol has on opioid exposure when used as an adjunct to the current standard multi-modal pain regimen (MMPR)

Eligibility Criteria

This trial is for patients at Memorial Herman Hospital-Texas Medical Center who are admitted with traumatic injuries and receiving standard pain management. It's not open to those who left against medical advice, prisoners, burn injury victims, non-acute trauma cases, the very ill (moribund), or pregnant women.

Inclusion Criteria

Patients admitted to the floor, Surgical Intermediate Medical Unit (SIMU), Shock-Trauma ICU (STICU) at Memorial Herman Hospital-Texas Medical Center(MHH-TMC)

Exclusion Criteria

Prisoner

I am currently under observation in a hospital.

I have an injury that is not recent or severe.

+6 more

Participant Groups

The study is testing if Dronabinol can reduce the need for opioids in managing pain when added to the usual multi-modal pain regimen. Patients will either receive this additional treatment or continue with their standard care without it.

2Treatment groups

Experimental Treatment

Active Control

Group I: Treatment Strategy #2Experimental Treatment2 Interventions

Group II: Treatment Strategy #1Active Control1 Intervention